JP2014515352A - シアリダーゼ阻害剤を用いた血小板の保存の改善法 - Google Patents

シアリダーゼ阻害剤を用いた血小板の保存の改善法 Download PDF

Info

Publication number
JP2014515352A
JP2014515352A JP2014511561A JP2014511561A JP2014515352A JP 2014515352 A JP2014515352 A JP 2014515352A JP 2014511561 A JP2014511561 A JP 2014511561A JP 2014511561 A JP2014511561 A JP 2014511561A JP 2014515352 A JP2014515352 A JP 2014515352A
Authority
JP
Japan
Prior art keywords
platelet
platelets
sialidase
source
pas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014511561A
Other languages
English (en)
Japanese (ja)
Inventor
キヨン ピーター リュー
カリン ホフマイスター
ロバート サックステイン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Priority claimed from US13/474,679 external-priority patent/US20120294842A1/en
Priority claimed from US13/474,473 external-priority patent/US20120321601A1/en
Publication of JP2014515352A publication Critical patent/JP2014515352A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/124—Disinfecting agents, e.g. antimicrobials
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2014511561A 2011-05-17 2012-05-17 シアリダーゼ阻害剤を用いた血小板の保存の改善法 Pending JP2014515352A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201161487077P 2011-05-17 2011-05-17
US61/487,077 2011-05-17
US201161503984P 2011-07-01 2011-07-01
US61/503,984 2011-07-01
US201261613837P 2012-03-21 2012-03-21
US201261613876P 2012-03-21 2012-03-21
US61/613,837 2012-03-21
US61/613,876 2012-03-21
US13/474,679 US20120294842A1 (en) 2011-05-17 2012-05-17 Platelet Additive Solution Having a Sialidase Inhibitor
US13/474,679 2012-05-17
PCT/US2012/038462 WO2012158983A2 (en) 2011-05-17 2012-05-17 Improved platelet storage using a sialidase inhibitor
US13/474,473 US20120321601A1 (en) 2011-05-17 2012-05-17 Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase Inhibitor
US13/474,627 US20120321722A1 (en) 2011-05-17 2012-05-17 Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor
US13/474,473 2012-05-17
US13/474,627 2012-05-17

Publications (1)

Publication Number Publication Date
JP2014515352A true JP2014515352A (ja) 2014-06-30

Family

ID=49716421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511561A Pending JP2014515352A (ja) 2011-05-17 2012-05-17 シアリダーゼ阻害剤を用いた血小板の保存の改善法

Country Status (6)

Country Link
EP (1) EP2709446A2 (de)
JP (1) JP2014515352A (de)
CN (1) CN103702556A (de)
AU (1) AU2012255137A1 (de)
CA (1) CA2835434A1 (de)
WO (1) WO2012158983A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017065280A1 (ja) * 2015-10-14 2017-04-20 株式会社メガカリオン 精製血小板の製造方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
EP2903430A1 (de) * 2012-10-05 2015-08-12 Velico Medical, Inc. Plättchenadditivlösung mit beta-galactosidase-inhibitor
CN114558032B (zh) * 2012-12-21 2025-07-29 安斯泰来再生医药协会 由多能干细胞制备血小板的方法及其组合物
WO2014120886A1 (en) * 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
WO2016057041A1 (en) * 2014-10-09 2016-04-14 Biovec Transfusion, Llc Compositions and methods for preserving platelet function
WO2016164693A1 (en) 2015-04-10 2016-10-13 Board Of Regents, The University Of Texas System Compositions and methods for prolonged cell storage
WO2017002045A1 (en) 2015-06-30 2017-01-05 Stemlab, Sa A viable cell population, method for production and uses thereof
CN111235132A (zh) * 2019-12-23 2020-06-05 浙江工业大学 一种β-半乳糖苷酶、基因、工程菌及其应用
CN117717059A (zh) * 2022-09-09 2024-03-19 河络新图生物科技(上海)有限公司 一种血小板保存液及其制备方法和用途

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412835A (en) 1982-07-06 1983-11-01 E. I. Du Pont De Nemours & Company Sterile docking process, apparatus and system
US5256559A (en) 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
SE8801537D0 (sv) 1988-04-26 1988-04-26 Ellco Food Ab Cellodlingsmedium samt forfarande for dess framstellning
US5135916A (en) 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
US5152905A (en) 1989-09-12 1992-10-06 Pall Corporation Method for processing blood for human transfusion
US5236716A (en) 1990-02-12 1993-08-17 Miles Inc. Platelets concentrate with low white blood cells content
US5569579A (en) 1991-04-01 1996-10-29 Thomas Jefferson University Synthetic-based platelet storage media
US5376524A (en) 1991-04-01 1994-12-27 Thomas Jefferson University Platelet storage medium containing acetate and phosphate
US5269946A (en) 1991-05-22 1993-12-14 Baxter Healthcare Corporation Systems and methods for removing undesired matter from blood cells
US5234808A (en) 1991-10-30 1993-08-10 Thomas Jefferson University Acetate addition to platelets stored in plasma
US5344752A (en) 1991-10-30 1994-09-06 Thomas Jefferson University Plasma-based platelet concentrate preparations
US5474891A (en) 1991-10-30 1995-12-12 Thomas Jefferson University Plasma-based platelet concentrate preparations with additive
WO1996014740A1 (en) 1992-03-02 1996-05-23 Cerus Corporation Synthetic media for blood components
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
US5529821A (en) 1992-06-29 1996-06-25 Terumo Kabushiki Kaisha Container for storing blood or blood component
US5571686A (en) 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets
US5582821A (en) 1994-07-22 1996-12-10 Genetics Institute, Inc. Methods for treating bleeding disorders
US6221669B1 (en) 1994-10-19 2001-04-24 Lifecell Corporation Prolonged preservation of blood platelets
US5919614A (en) 1994-10-19 1999-07-06 Lifecell Corporation Composition comprising three platelet lesion inhibitors for platelet storage
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
DE69532236D1 (de) 1994-12-16 2004-01-15 Baxter Int Antikoagulierende Zusammensetzungen für Blutplättchen
JP2930908B2 (ja) 1995-07-19 1999-08-09 川澄化学工業株式会社 血小板保存液
TW499412B (en) 1996-11-26 2002-08-21 Dimensional Pharm Inc Aminoguanidines and alkoxyguanidines as protease inhibitors
JP2001524467A (ja) 1997-11-26 2001-12-04 ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド ヘテロアリールアミノグアニジンおよびアルコキシグアニジンおよびプロテアーゼインヒビターとしてのこれらの使用
EP1049495A2 (de) 1998-01-23 2000-11-08 Pall Corporation System zum verarbeiten von biologischen flüssigkeiten
US6344486B1 (en) 1998-04-03 2002-02-05 3-Dimensional Pharmaceuticals, Inc. Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
US6417161B1 (en) 1998-04-24 2002-07-09 3-Dimensional Pharmaceuticals, Inc. Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
PL344749A1 (en) 1998-06-11 2001-11-19 Dimensional Pharmaceuticals 3 Pyrazinone protease inhibitors
EP1189901A1 (de) 1999-05-27 2002-03-27 3-Dimensional Pharmaceuticals, Inc. Oxazaheterocyclen als proteasehemmer
US6420397B1 (en) 1999-07-09 2002-07-16 3-Dimensional Pharmaceuticals, Inc. Heteroaryl protease inhibitors and diagnostic imaging agents
PL208386B1 (pl) 2000-07-06 2011-04-29 Daiichi Sankyo Company Sole addycyjne 2-acetoksy-5-(α-cyklopropylokarbonylo-2-flurobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny z kwasem, lekarstwo zawierające jako składnik czynny te sole, zastosowanie soli, sposoby wytwarzania soli addycyjnych 2-acetoksy-5-(α-cyklopropylokarbonylo-2-fluorobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny z kwasem, sposób wytwarzania chlorowodorku 2-acetoksy-5-(α-cyklopropylokarbonylo-2-fluorobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny
JP2004504305A (ja) 2000-07-17 2004-02-12 ３−ディメンショナル　ファーマシューティカルズ，　インコーポレイテッド プロテアーゼインヒビターとしての環状オキシグアニジンピラジノン
US6635637B2 (en) 2000-08-04 2003-10-21 Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine protease inhibitors
UA75093C2 (en) 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
EP1331941A1 (de) 2000-10-13 2003-08-06 Pike Laboratories, Inc. Kalte aufbewahrungslösung für die konservierung von organen und biologischen geweben
US6605302B2 (en) 2001-07-17 2003-08-12 Osmotica Corp. Drug delivery device containing oseltamivir and an H1 antagonist
WO2004098675A2 (en) 2003-05-01 2004-11-18 Thermics, Llc Method and system for warming a fluid
WO2006025983A2 (en) 2004-07-26 2006-03-09 The Regents Of The University Of California Labeled substrate conjugates for identifying enzyme inhibitors
US8052667B2 (en) 2004-09-07 2011-11-08 Velico Medical, Inc. Apparatus for prolonging survival of platelets
AU2005295467B2 (en) * 2004-10-15 2011-07-07 Velico Medical, Inc. Compositions and methods for prolonging survival of platelets
US20090175805A1 (en) 2006-03-13 2009-07-09 The Trustees Of Columbia University In The City Of New York Neuraminidase Inhibitors and uses thereof
WO2008011094A2 (en) 2006-07-18 2008-01-24 Robert Sackstein Cytokine induction of selectin ligands on cells
CN101181302A (zh) * 2007-11-29 2008-05-21 中国人民解放军军事医学科学院野战输血研究所 一种保养液以及一种血小板保存液

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017065280A1 (ja) * 2015-10-14 2017-04-20 株式会社メガカリオン 精製血小板の製造方法
JPWO2017065280A1 (ja) * 2015-10-14 2018-09-13 株式会社メガカリオン 精製血小板の製造方法
US10851343B2 (en) 2015-10-14 2020-12-01 Megakaryon Corporation Method for producing purified platelets
JP7287634B2 (ja) 2015-10-14 2023-06-06 株式会社メガカリオン 精製血小板の製造方法

Also Published As

Publication number Publication date
AU2012255137A1 (en) 2013-12-12
WO2012158983A3 (en) 2014-01-03
WO2012158983A2 (en) 2012-11-22
CA2835434A1 (en) 2012-11-22
CN103702556A (zh) 2014-04-02
EP2709446A2 (de) 2014-03-26

Similar Documents

Publication Publication Date Title
US20190246629A1 (en) Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor
AU2012255137A1 (en) Improved platelet storage using a sialidase inhibitor
AU2003290677B2 (en) Compositions and methods for prolonging survival of platelets
JP5450958B2 (ja) 血小板の生存延長のための組成物および方法
US8221745B2 (en) Prolonging survival of platelets using CMP-sialic acid,UDP-galactose or both
JP2014039546A (ja) 血小板の生存延長のための組成物および方法
US20190200602A1 (en) Platelet Additive Solution Having a Beta-Galactosidase Inhibitor
US20190203175A1 (en) Platelet Protection Solution Having a Beta-Galactosidase Inhibitor
WO2014120886A1 (en) Platelet additive solution having a self-assembling hydrogel-forming peptide
US20120294842A1 (en) Platelet Additive Solution Having a Sialidase Inhibitor
US9788539B2 (en) Platelet protection solution having beta-galactosidase and sialidase inhibitors